Table 1.
Patient Characteristics, n | Year of Initial ESKD Onset or Wait List Placement, % | ||||
---|---|---|---|---|---|
1997–2000, n=217,989 | 2001–2004, n=244,601 | 2005–2008, n=270,258 | 2009–2012, n=284,772 | 2013–2016, n=292,378 | |
Age at ESKD onset | |||||
18–39, n=154,749 | 14.4 | 12.6 | 11.8 | 10.9 | 10.3 |
40–49, n=214,610 | 17.9 | 17.4 | 16.7 | 15.6 | 14.9 |
50–59, n=383,385 | 27.2 | 29.4 | 30.5 | 29.8 | 29.0 |
60–70, n=557,254 | 40.5 | 40.6 | 41.0 | 43.8 | 45.8 |
Race/ethnicity | |||||
Non-Hispanic White, n=603,369 | 46.8 | 45.8 | 45.7 | 46.0 | 46.1 |
Non-Hispanic Black, n=421,801 | 33.5 | 33.4 | 30.0 | 31.2 | 30.4 |
Asian, n=40,855 | 2.7 | 2.9 | 3.1 | 3.3 | 3.6 |
Hispanic White, n=191,078 | 11.5 | 13.1 | 14.6 | 16.2 | 16.6 |
Hispanic Black, n=6361 | 0.6 | 0.5 | 0.5 | 0.5 | 0.4 |
Other, n=46,534 | 4.9 | 4.3 | 3.1 | 2.9 | 2.9 |
Sex | |||||
Women, n=562,886 | 45.7 | 44.4 | 42.9 | 41.7 | 41.0 |
Men, n=746,977 | 54.3 | 55.6 | 57.1 | 58.3 | 59.0 |
Unknown, n=135 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 |
Primary diagnosis | |||||
Diabetes, n=642,778 | 48.9 | 49.0 | 48.2 | 48.5 | 50.6 |
Hypertension, n=298,072 | 20.6 | 21.2 | 21.8 | 23.5 | 25.8 |
GN, n=145,895 | 13.9 | 12.5 | 11.2 | 10.1 | 8.8 |
Cystic disease, n=40,470 | 3.2 | 3.1 | 3.3 | 3.1 | 2.8 |
Other/missing, n=182,783 | 13.4 | 14.1 | 15.5 | 14.8 | 12.0 |
BMI, kg/m2 | |||||
13–18, n=38,482 | 5.5 | 3.1 | 2.6 | 2.2 | 2.0 |
19–24, n=276,845 | 25.5 | 24.3 | 20.8 | 18.5 | 18.1 |
25–29, n=365,309 | 27.6 | 29.8 | 28.2 | 27.3 | 26.8 |
30–34, n=265,657 | 16.3 | 19.6 | 20.7 | 21.6 | 22.1 |
35–39, n=154,884 | 7.9 | 10.6 | 12.1 | 13.5 | 13.9 |
40+, n=158,432 | 6.7 | 9.9 | 12.7 | 14.6 | 15.0 |
Missing, n=50,389 | 10.5 | 2.7 | 2.9 | 2.5 | 2.1 |
ESKD network | |||||
(S-CA) Southern California Network, n=97,068 | 7.0 | 7.5 | 7.2 | 7.5 | 7.7 |
(N-CA) Trans-Pacific ESRD Network, n=62,034 | 4.7 | 4.6 | 4.7 | 4.8 | 4.9 |
(WA) Northwest Renal Network, n=36,239 | 2.6 | 2.7 | 2.7 | 3.0 | 2.9 |
(CO) Inter-Mountain ESRD Network, n=61,848 | 4.4 | 4.6 | 4.7 | 4.9 | 4.9 |
(TX) Network of Texas, n=119,147 | 8.0 | 8.4 | 8.9 | 9.4 | 10.3 |
(OK) ESRD Network 13, n=58,976 | 4.6 | 4.6 | 4.4 | 4.4 | 4.5 |
(MO) ESRD Network 12, n=47,957 | 3.8 | 3.6 | 3.7 | 3.6 | 3.7 |
(MN) Renal Network of Upper Midwest, n=81,884 | 6.4 | 6.5 | 6.5 | 6.1 | 5.9 |
(IL) Renal Network of Illinois, n=55,605 | 4.4 | 4.3 | 4.3 | 4.2 | 4.0 |
(IN) Tri-State R. N., n=96,347 | 7.3 | 7.3 | 7.4 | 7.5 | 7.3 |
(MS) Network 8, n=76,491 | 5.7 | 5.6 | 5.9 | 5.9 | 6.0 |
(FL) ESRD Network of Florida, n=76,617 | 5.5 | 5.6 | 5.9 | 6.1 | 6.1 |
(NC) Southeastern Kidney Council, n=122,919 | 9.2 | 9.3 | 9.5 | 9.3 | 9.6 |
(VA) Mid-Atlantic R. C., n=79,256 | 6.4 | 6.4 | 6.2 | 5.9 | 5.6 |
(PA) ESRD Network Organization, n=56,443 | 4.7 | 4.4 | 4.4 | 4.2 | 3.9 |
(NJ) Trans-Atlantic R. C., n=58,218 | 4.9 | 4.7 | 4.4 | 4.3 | 4.1 |
(NY) Network of New York, n=80,726 | 6.9 | 6.5 | 6.1 | 5.8 | 5.7 |
(CT) Network of New England, n=41,527 | 3.5 | 3.3 | 3.2 | 3.0 | 2.9 |
Missing, n=696 | 0.1 | 0.1 | <0.1 | <0.1 | <0.1 |
Comorbid conditions | |||||
Congestive heart failure, n=335,151 | 26.3 | 25.7 | 26.6 | 25.4 | 24.2 |
Cancer, n=60,005 | 3.6 | 4.1 | 5.0 | 5.2 | 4.8 |
Atherosclerotic heart disease, n=212,996 | 20.6 | 20.8 | 16.2 | 14.6 | 10.9 |
Tobacco use, n=98,508 | 6.6 | 6.5 | 8.0 | 8.2 | 8.0 |
Hypertension, n=1,087,041 | 75.3 | 80.0 | 83.8 | 86.2 | 87.4 |
Alcohol abuse, n=27,311 | 2.0 | 1.8 | 2.2 | 2.3 | 2.1 |
Peripheral vascular disease, n=144,161 | 12.2 | 11.6 | 11.8 | 10.8 | 9.2 |
Median household income level, $ | |||||
<29,000, n=108,464 | 6.7 | 6.3 | 9.1 | 9.6 | 9.1 |
29,001–36,000, n=154,661 | 10.0 | 9.9 | 12.1 | 12.8 | 13.5 |
36,001–47,000, n=352,327 | 26.0 | 25.8 | 27.2 | 27.9 | 27.2 |
47,001–61,000, n=335,675 | 27.7 | 28.1 | 24.9 | 24.0 | 24.3 |
61,001–80,000, n=209,576 | 17.0 | 17.5 | 15.6 | 15.2 | 15.1 |
>80,000, n=127,359 | 10.4 | 10.9 | 9.4 | 8.9 | 9.4 |
Missing, n=21,936 | 2.2 | 1.7 | 1.7 | 1.5 | 1.4 |
All patients | 16.6 | 18.7 | 20.6 | 21.7 | 22.3 |
S-CA, Southern California; N-CA, Northern California; R. N., renal network; R. C., renal coalition.